This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: China Medical University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Yuh-Pyng Sher: Innovator in ADAM9 Inhibition
Introduction
Yuh-Pyng Sher is a prominent inventor based in Taichung, Taiwan. She has made significant contributions to the field of medical research, particularly in the development of compounds that can improve health outcomes. Her work focuses on innovative solutions that address critical health issues.
Latest Patents
Yuh-Pyng Sher holds a patent for a composition that includes an ADAM9 inhibitor. This patent, titled "Composition including ADAM9 inhibitor and the use thereof," describes a compound of formula (I), which includes salts, hydrates, and stereoisomers. The patent outlines methods for using this compound to treat individuals in need, demonstrating its potential to enhance health and improve conditions.
Career Highlights
Yuh-Pyng Sher is affiliated with China Medical University, where she conducts her research and development activities. Her work has garnered attention for its innovative approach to addressing health challenges through the use of specific compounds.
Collaborations
Yuh-Pyng Sher collaborates with esteemed colleagues, including Yang-Chang Wu and Juan-Cheng Yang. These partnerships enhance her research efforts and contribute to the advancement of medical science.
Conclusion
Yuh-Pyng Sher's contributions to the field of medical research, particularly through her patent on ADAM9 inhibitors, highlight her role as an influential inventor. Her work continues to pave the way for innovative treatments that can significantly impact health outcomes.